Although the counter structures for VISTA have not been comprehensively elucidated, recent in vitro findings on V-Set and immunoglobulin domain containing 3 (VSIG-3) have shown that VISTA also acts as a co-inhibitory ligand on tumor cells (Wang et al., 2019). This evidence concerns the gene VSIR and neoplasm.